Literature DB >> 2779711

Increased ultrafiltration after erythropoietin-induced correction of renal anemia in patients on continuous ambulatory peritoneal dialysis.

H B Steinhauer, I Lubrich-Birkner, K W Dreyling, W H Hörl, P Schollmeyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2779711     DOI: 10.1159/000185716

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  6 in total

1.  Subcutaneous r-HuEPO therapy in CAPD patients: dose determination and clinical experience.

Authors:  L Janicka; A Ksiazek; I Baranowicz; A Bednarek-Skublewska; P Mierzicki; P Ksiazek
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 2.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

Review 3.  Duchenne muscular dystrophy.

Authors:  Dongsheng Duan; Nathalie Goemans; Shin'ichi Takeda; Eugenio Mercuri; Annemieke Aartsma-Rus
Journal:  Nat Rev Dis Primers       Date:  2021-02-18       Impact factor: 52.329

Review 4.  Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).

Authors:  I C Macdougall; D E Roberts; G A Coles; J D Williams
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

5.  Non-cardiac benefits of human recombinant erythropoietin in end stage renal failure and anaemia.

Authors:  K P Morris; J Sharp; S Watson; M G Coulthard
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

Review 6.  Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.

Authors:  D Faulds; E M Sorkin
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.